DENDREON CORPORATION (DNDNQ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
601 UNION STREET, SUITE 4900, SEATTLE, WA 98101
888-369-8915

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 20.001 Million Shares Outstanding157.49 Million Avg 30-day Volume 11.255 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.7645 Debt to Equity-1.8533 EBITDA-51.774 Million
Price to Book Value0.0 Operating Margin-36.3902 Enterprise Value690.981 Million
Current Ratio3.506 EPS Growth0 Quick Ratio2.006
1 Yr BETA 0.7854 52-week High/Low 0.0 / Profit Margin-54.3451
Operating Cash Flow Growth63.3336 Free Cash Flow to Firm (FCFF) TTM -15.667 Million Free Cash Flow to Equity (FCFE) TTM-46.114 Million
Altman Z-Score-8.9731
View SEC Filings from DNDNQ instead.

View recent insider trading info

DENDREON CORPORATION YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DNDNQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DNDNQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BROPHY KAREN VP, HUMAN RESOURCES

  • Officer
 No longer subject to file 2015-02-23 0

PACHECO SILVIO SVP, SALES AND MARKETING

  • Officer
 No longer subject to file 2015-02-23 0

CROTTY ROBERT EVP, GENERAL COUNSEL

  • Officer
 97,855 2015-02-17 0

COX GREG EVP, CFO & TREASURER

  • Officer
 177,754 2015-02-13 0

MONTEITH WILLIAM EVP, TECHNICAL OPERATIONS

  • Officer
 209,875 2015-02-13 0

SANDLER ANDREW SETH EVP, CHIEF MEDICAL OFFICER

  • Officer
 207,914 2015-02-13 0

JENKINSON WILLIAM CHIEF MARKETING OFFICER

  • Officer
 98,436 2014-08-31 0

ROCCO LINDSAY EVP, CORPORATE COMMUNICATIONS

  • Officer
 122,998 2014-08-15 0

AMICK W THOMAS PRES & CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 125,000 2014-07-31 0

JOHNSON JOHN PRES & CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 1,071,125 2014-07-03 0

CVIJIC CHRISTINE MIKAIL EVP, CORP DEV, GEN CNSL/SCRTRY

  • Officer
 351,465 2014-02-10 0

DEPINTO JOSEPH I EVP, GLOBAL COMMERCIAL OPS

  • Officer
 136,694 2014-01-31 0

FROHLICH MARK W EVP, R&D AND CMO

  • Officer
 525,283 2014-01-20 0

WATSON DOUGLAS G

  • Director
 104,757 2014-01-03 0

FENTON DENNIS M

  • Director
 75,000 2014-01-03 0

STUMP DAVID C

  • Director
 82,047 2014-01-03 0

BAYH SUSAN B

  • Director
 115,757 2014-01-03 0

GRANADILLO PEDRO P

  • Director
 87,251 2014-01-03 0

URDAL DAVID

  • Director
 644,750 2014-01-03 0

DZIURZYNSKI BOGDAN

  • Director
 103,507 2014-01-03 0

SCHIFFMAN GREGORY T EVP

  • Officer
 441,924 2013-10-20 0

RANIERI RICHARD J EVP, HUMAN RESOURCES

  • Officer
 224,831 2013-01-31 0

MAYES, GREGORY T. EVP HUMAN RESOURCES

  • Officer
 150,000 2013-01-31 0

CANET GERARDO

  • Director
 74,757 2013-01-03 0

GOLD MITCHELL

  • Director
 457,263 2013-01-03 0

POULTON ROBERT S EVP, TECHNICAL OPERATIONS

  • Officer
 112,957 2013-01-03 0

BREWER RICHARD B

  • Director
 45,157 2012-01-03 0

OSBORN JOHN E EVP, GENERAL COUNSEL

  • Officer
 187,000 2012-01-03 0

BISHOP HANS EDGAR CHIEF OPERATING OFFICER

  • Officer
 151,189 2011-07-29 0

HAMM RICHARD F JR EVP, GENERAL COUNSEL SECRETARY

  • Officer
 180,633 2011-05-23 0

CLARK IAN T BOARD OF DIRECTOR

  • Director
 0 2010-08-20 0

INGLE M BLAKE

  • Director
 12,500 2009-04-29 0

KUNATH RUTH

  • Director
 28,671 2007-12-05 0

HERSHBERG ROBERT SR. VP & CHIEF MEDICAL OFFICER

  • Officer
 15,724 2006-01-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments